- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
When Statin Guidelines Collide: 5 Questions on 2 Approaches to Primary CVD Prevention
Guidelines on primary ASCVD prevention from the USPSTF and the AHA/ACC/Multisociety differ on why and when to initiate a statin. Try the 5-question quiz.
Clinical guidelines on the primary prevention of atherosclerotic cardiovascular disease (ASCVD) from the United States Preventative Services Taskforce (USPSTF; 2022)1 and the American Heart Association/American College of Cardiology/Multisociety ( AHA/ACC/MS; 2018),2 are 2 of the leading resources for evidence-based recommendations on how to mitigate risk of a first CVD event. They differ, however, in the risk factors that suggest and level of risk at which a statin should be initiated.
The following 5 questions test what you know about the differences and the benefit-risk balance of statin therapy.
